JP Morgan Chase’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-100
Closed -$9.04K 7698
2026
Q1
$9.04K Buy
+100
New +$8.86K ﹤0.01% 6769

Other funds holding ACLS

JP Morgan Chase's ACLS Position: Q2 2026 in Review

JP Morgan Chase reduced its Axcelis (ACLS) stake by 80% in Q2 2026, selling an estimated $26.5M and leaving 44,011 shares worth $8M. The position accounts for ﹤0.01% of the portfolio, ranked #3019.

JP Morgan Chase first reported a position in ACLS in Q2 2013 and has held it in 46 quarters since. The position peaked at $73.2M in Q4 2023. 440 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • JP Morgan Chase held 44,011 shares of Axcelis worth $8M as of Q2 2026.
  • JP Morgan Chase sold 178,703 Axcelis shares in Q2 2026, an estimated $26.5M.
  • Axcelis made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3019 holding.
  • JP Morgan Chase first reported a position in Axcelis in Q2 2013 and has held it in 46 quarters since.
  • JP Morgan Chase's Axcelis position peaked at $73.2M in Q4 2023.
  • 440 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.